期刊文献+

慢性ITP患者外周血NO/NOS、ROS的检测及临床意义 被引量:9

The detection and clinical significance of peripheral blood NO/NOS and ROS in patients with chronic ITP
下载PDF
导出
摘要 目的:检测慢性特发性血小板减少性紫癜(Idiopathic thrombocytopenic purpura,ITP)患者血清一氧化氮(NO)、一氧化氮合酶(NOS)、活性氧(ROS)含量,探讨NO与ROS、NOS与ROS之间的相关性。方法:设立慢性ITP患者组与健康对照组,ELISA法检测外周血中NO及NOS的表达,ELISA法检测外周血ROS浓度。结果:慢性ITP患者组NO/NOS与ROS水平明显高于正常对照组[t(ROS)=1.24;t(NO)=0.91;t(NOS)=0.82,P均<0.01],ROS与NO/NOS水平分别正相关(r=0.817,r=0.861,P均<0.01)。结论:慢性ITP患者NO/NOS、ROS均升高且NO/NOS与ROS呈正相关,提示NO可能作为一种介质和自由基参与血小板的破坏,其作用在ITP发生中可能具有与ROS同样或协同的作用,NO/NOS、ROS的检测对慢性ITP的诊治具有潜在的临床指导意义。 Objective:To detect the serum NO/NOS, ROS content from the patients with chronic ITP, and explore the relationship between NO/NOS and ROS respectively. Method:Chronic ITP patients and healthy control group were set in this study, peripheral blood NO and NOS expression were detected with the ELISA assay, peripheral blood ROS concentrations was detected with ELISA assay also, then analyzed the correlation bewteen the NO/NOS and ROS. Results: NO/NOS and ROS levels in patients with chronic ITP group were significantly higher than the control group It (ROS) = 1.24; t (NO) = 0.91; t (NOS) = 0.82,all P〈 0. 01 ], ROS and NO/NOS levels were positively correlated (r = 0. 817, r = 0. 861, all P 〈0.01). Conclusion:Elevated ROS may have a certain relationship with the destruction of megakaryocytes and platelets in patients with chronic ITP, elevated NO/NOS and positively correlated with ROS suggests that NO may be a medium and radicals involved in the destruction of megakaryocytes and platelets, and they may have a synergistic effect with ROS. The detection of NO/NOS and ROS may have clinical significances in the diagnosis and treatment of chronic ITP.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2013年第4期392-394,399,共4页 Chinese Journal of Immunology
基金 山东省自然科学基金资助项目(ZR2010HL038) 济宁市科技发展计划资助项目(2012jnjc16)
关键词 慢性特发性血小板减少性紫癜 一氧化氮 一氧化氮合酶 活性氧 Idiopathic thrombocytopenic purpura Nitrogen monoxide Nitric oxide synthase Reactive oxygen species
  • 相关文献

参考文献10

  • 1Gernsheimer T. Epidemiology and pathophysiology of immune throm- boeytopenic purpura [ J ]. Eur J Haematol Suppl,2008 ;2 ( 69 ) :3-8.
  • 2Gernsheimer T. Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis [ J ]. Oncologist, 2009 ; 14 ( 1 ) : 12-21.
  • 3Arslan F, Akarsu S, Kara Met al. eNOS Glu298Asp gene polymorphism in the cases of idiopathic thrombocytopenic purpura [ J ]. J Thrombosis and Haemostasis, 2009 ; 7 ( Supplement 2 ) : Abstract PP- WE-709.
  • 4Chapple I L. Reactive oxygen species and antroxidants in inflammatory disease [ J ]. J Clin Periodontol, 1997 ; 24 ( 5 ) : 287-296.
  • 5Alvarez-Larran A, Petriz J, Martinez A et al. Plasma from patients with thrombotic thrombocytopenic purpura induces activation of human monocytes and polymorphonuclear neutrophils [J]. Br J Haematol, 2003 ; 120( 1 ) : 129-134.
  • 6Ruiz-Torres M P, Casiraghi F, Galbusera Met al. Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies [ J ] Thromb Haemost ,2005 ;93 ( 3 ) :443-452.
  • 7Higurashi S, Machino Y, Suzuki E et al. Both the Fab and Fc domains of IgG are essential for ROS emission from TNF-a-primed neutrophils by IVIG [J]. Biochem Biophys Res Commun,2012 ;417 (2) :794-799.
  • 8Biro C, Kopani M, Kopaniova A et al. Iron accumulation in human spleen in autoimmune thromboeytopenia and hereditary spherocytosis [J]. Bratisl Lek Listy, 2012;113(2) :92-94.
  • 9金呈强 刘仿 肖红 等.活化的PPAR-γ对Jurkat系T肿瘤细胞NO生成诱导的研究.中国免疫学杂志,2008,24:6-6.
  • 10王文龙,金呈强,刘仿,高岩,盛蕊,王文涓,肖红,周细玉.PPAR-γ配体对ITP模型小鼠NO生成诱导时间效应的研究[J].中国免疫学杂志,2010,26(7):591-594. 被引量:4

二级参考文献14

  • 1金呈强 刘仿 肖红 等.活化的PPAR-γ对Jurkat系T肿瘤细胞NO生成诱导的研究.中国免疫学杂志,2008,24:6-6.
  • 2Beardsley D S. Pathophysiology of immune thrombocytopenic purpura[ J ]. Blood Rev,2002; 16(1) : 13-14.
  • 3Racke M K, Gocke A R, Muir M et al. Nuclear receptors and autoimmune disease: the potential of PPAR agouists to treat multiple sclerosis [ J ]. J Nutr, 2006 ; 136 (3) : 700-703.
  • 4WU C L, XU J C, LI F et al. Polarization and apoptosis of T cell subsets in idiopathic thrombocytopenic purpura [ J ]. lnt J Lab Hematol, 2007 ; 29 (3) : 177-184.
  • 5Kasono K, Nishida J, Tamemoto H et al. Thiazolidinediones increase the number of platelets in immune thrombocylopenic purpura mice via inhibition of phagocytic activity of the reticulo-endothelial system[J]. Life Sci, 2002 ; 17 : 2037-52.
  • 6Waits G F, Staels B. Regulation of endothclial Nitric Oxide synthase by PPAR agonists: molecular and clinical pcrspectives [ J ]. Arterioscler Thromb Vase Biol, 2004 ; 24 : 619-621.
  • 7Napimoga M H, Vieira S M, Dal-Secco D et al. Peroxisome proliferatoractivated receptor-γ ligand, 15- Deoxy- △ 12, 14-pmstaglmldin J2, reduces neutrophil migration via a Nitric Oxide pathway [ J ]. J Immunol, 2008; 180:609-617.
  • 8Goya Kayoko, Sumitani Satom, Xu Xin et al. Peroxisome proliferator-activated receptor a agonists increase nitric oxide synthase expression in vascular endothelial cells [ J ]. Arterioscler Thromb Vasc Biol, 2004; 24 (4) : 658-663.
  • 9Cho D H, Choi Y J, Jo S A et al. Nitric Oxide produetion and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with Troglitazone [ J ]. J Biol Chem, 2004 ; 279 (4) : 2499-2506.
  • 10Goya K, Sumitani S, Otsuki M et al. The thiazolidinedione drug tmglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells [ J ]. J Diabetes Complications, 2006 ; 20 ( 5 ) : 336-342.

共引文献5

同被引文献94

引证文献9

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部